NeuroPace, Inc.
NPCE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $27,354 | $23,520 | $22,524 | $21,466 |
| % Growth | 16.3% | 4.4% | 4.9% | – |
| Cost of Goods Sold | $6,186 | $5,388 | $5,182 | $5,278 |
| Gross Profit | $21,168 | $18,132 | $17,342 | $16,188 |
| % Margin | 77.4% | 77.1% | 77% | 75.4% |
| R&D Expenses | $6,576 | $6,845 | $7,440 | $6,050 |
| G&A Expenses | $4,594 | $6,068 | $0 | $0 |
| SG&A Expenses | $17,192 | $18,111 | $15,049 | $13,791 |
| Sales & Mktg Exp. | $12,598 | $12,043 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $23,768 | $24,956 | $22,489 | $19,841 |
| Operating Income | -$2,600 | -$6,824 | -$5,147 | -$3,653 |
| % Margin | -9.5% | -29% | -22.9% | -17% |
| Other Income/Exp. Net | -$896 | -$1,827 | -$1,442 | -$1,597 |
| Pre-Tax Income | -$3,496 | -$8,651 | -$6,589 | -$5,250 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,496 | -$8,651 | -$6,589 | -$5,250 |
| % Margin | -12.8% | -36.8% | -29.3% | -24.5% |
| EPS | -0.11 | -0.26 | -0.21 | -0.18 |
| % Growth | 57.7% | -23.8% | -16.7% | – |
| EPS Diluted | -0.11 | -0.26 | -0.21 | -0.18 |
| Weighted Avg Shares Out | 33,135 | 32,863 | 31,481 | 29,915 |
| Weighted Avg Shares Out Dil | 33,135 | 32,863 | 31,481 | 29,915 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $718 | $793 | $681 |
| Interest Expense | $978 | $2,059 | $2,153 | $2,192 |
| Depreciation & Amortization | $54 | $477 | $462 | $451 |
| EBITDA | -$2,464 | -$6,115 | -$3,974 | -$2,607 |
| % Margin | -9% | -26% | -17.6% | -12.1% |